The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Bisphosphonate-related osteonecrosis of the jaws – Characteristics, risk factors, clinical features, localization and impact on oncological treatment
Abstract
INTRODUCTION Osteonecrosis of the jaw (ONJ) is a serious side-effect of intravenous nitrogen-containing bisphosphonate therapy frequently used in the treatment of malignant diseases. Despite numerous case series published so far studies with detailed investigations into risk factors, the precise localization of ONJ and impact of ONJ on the oncological treatment remain sparse. PATIENTS AND METHODS This single-centre study collated medical records (2003-2009) of all patients that suffered from ONJ within the Department of Oral and Maxillofacial Surgery, Ludwig-Maximilians-University of Munich, Germany. In total, 126 patients fulfilled the case criteria of ONJ and were examined clinically. The complete medical history including detailed questionnaires was collected of 66 patients, focussing in particular on the identification of underlying risk factors, clinical features, ONJ localization as well as the impact on the oncological treatment. RESULTS The majority of ONJ cases occurred in patients suffering from malignant diseases (n=117; 92.8%), in particular breast cancer (n=57; 45.2%), multiple myeloma (n=37; 29.4%) and prostate cancer (n=13; 10.3%), all received nitrogen-containing bisphosphonates intravenously. ONJ was also diagnosed in 9 patients (7.1%) suffering from osteoporosis or rheumatoid arthritis. The most prevalent clinical feature was exposed necrotic bone (93.9%) in the oral cavity which was accompanied in 78.8% of cases by pain. A predilection for the mandible and in particular for molar and premolar regions in both jaws was shown. Although no recommendation concerning the oncologic treatment was made, the manifestation of ONJ resulted (in a significant proportion of the patients) in a change of medication and schedule. The most frequent co-medications were steroids and anti-angiogenetic drugs, such as thalidomide. DISCUSSION The predilection for mandibular molar and premolar regions, and the infectious conditions that often precede the onset of ONJ support recent pathogenesis theories stating that local inflammation and associated pH-changes may trigger the release and activation of nitrogen-containing bisphosphonates ultimately resulting in necrosis. CONCLUSION The development of ONJ has a multi-factorial aetiology and the clinical presentation can vary markedly. ONJ cannot only impair the quality of life but also the treatment of the underlying disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07088-2 · Cited by 3,846
Marx, R. E. (2003) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/s0278-2391(03)00720-1 · Cited by 3,036
Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases
Ruggiero, S. L., Mehrotra, B., Rosenberg, T. J., & Engroff, S. L. (2004) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2004.02.004 · Cited by 2,057
Khosla, S., Burr, D., Cauley, J., Dempster, D. W., Ebeling, P. R., Felsenberg, D., Gagel, R. F., Gilsanz, V., Guise, T., Koka, S., et al. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0707onj · Cited by 1,650
Ruggiero, S. L., Dodson, T. B., Assael, L. A., Landesberg, R., Marx, R. E., & Mehrotra, B. (2009) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2009.01.009 · Cited by 1,328
Osteonecrosis of the Jaw in Cancer After Treatment With Bisphosphonates: Incidence and Risk Factors
Bamias, A., Kastritis, E., Bamia, C., Moulopoulos, L. A., Melakopoulos, I., Bozas, G., Koutsoukou, V., Gika, D., Anagnostopoulos, A., Papadimitriou, C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.8670 · Cited by 1,149
Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma
Berenson, J. R., Lichtenstein, A., Porter, L., Dimopoulos, M. A., Bordoni, R., George, S., Lipton, A., Keller, A., Ballester, O., Kovacs, M. J., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602223340802 · Cited by 1,081
Sato, M., Grasser, W., Endo, N., Akins, R., Simmons, H., Thompson, D. D., Golub, E., & Rodan, G. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115539 · Cited by 1,004
(2007) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2006.11.003 · Cited by 837
Berenson, J. R., Lichtenstein, A., Porter, L., Dimopoulos, M. A., Bordoni, R., George, S., Lipton, A., Keller, A., Ballester, O., Kovacs, M., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.593 · Cited by 648
Hoff, A. O., Toth, B. B., Altundag, K., Johnson, M. M., Warneke, C. L., Hu, M., Nooka, A., Sayegh, G., Guarneri, V., Desrouleaux, K., et al. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080205 · Cited by 633
Berenson, J. R., Hillner, B. E., Kyle, R. A., Anderson, K., Lipton, A., Yee, G. C., & Biermann, J. S. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.06.037 · Cited by 542
Bisphosphanates and Oral Cavity Avascular Bone Necrosis
Migliorati, C. A. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.99.132 · Cited by 480
Meta-Analyses of Therapies for Postmenopausal Osteoporosis
Osteoporosis Methodology Group, & The Osteoporosis Research Advisory Group (2002) · Endocrine Reviews · doi:10.1210/edrv.23.4.0486 · Cited by 471
The Pathogenesis of Bisphosphonate-Related Osteonecrosis of the Jaw: So Many Hypotheses, So Few Data
Allen, M. R., & Burr, D. B. (2009) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2009.01.007 · Cited by 451
Dimopoulos, M. A., Kastritis, E., Bamia, C., Melakopoulos, I., Gika, D., Roussou, M., Migkou, M., Eleftherakis-Papaiakovou, E., Christoulas, D., Terpos, E., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn554 · Cited by 437
Ripamonti, C. I., Maniezzo, M., Campa, T., Fagnoni, E., Brunelli, C., Saibene, G., Bareggi, C., Ascani, L., & Cislaghi, E. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn526 · Cited by 405
Hansen, T., Kunkel, M., Weber, A., & James Kirkpatrick, C. (2006) · Journal of Oral Pathology & Medicine · doi:10.1111/j.1600-0714.2006.00391.x · Cited by 368
Dimopoulos, M. A., Kastritis, E., Anagnostopoulos, A., Melakopoulos, I., Gika, D., Moulopoulos, L. A., Bamia, C., Terpos, E., Tsionos, K., & Bamias, A. (2006) · PubMed · Cited by 340
Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases
Filleul, O., Crompot, E., & Saussez, S. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0907-7 · Cited by 295
Roelofs, A. J., Jauhiainen, M., Mönkkönen, H., Rogers, M. J., Mönkkönen, J., & Thompson, K. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07435.x · Cited by 289
VI. Meta-Analysis of Calcitonin for the Treatment of Postmenopausal Osteoporosis
Cranney, A., Tugwell, P., Zytaruk, N., Robinson, V., Weaver, B., Shea, B., Wells, G., Adachi, J., Waldegger, L., Guyatt, G., et al. (2002) · Endocrine Reviews · doi:10.1210/er.2001-6002 · Cited by 286
III. Meta-Analysis of Risedronate for the Treatment of Postmenopausal Osteoporosis
Cranney, A., Tugwell, P., Adachi, J., Weaver, B., Zytaruk, N., Papaioannou, A., Robinson, V., Shea, B., Wells, G., & Guyatt, G. (2002) · Endocrine Reviews · doi:10.1210/er.2001-3002 · Cited by 281
Boonyapakorn, T., Schirmer, I., Reichart, P. A., Sturm, I., & Massenkeil, G. (2008) · Oral Oncology · doi:10.1016/j.oraloncology.2007.11.012 · Cited by 280
Sedghizadeh, P. P., Kumar, S. K. S., Gorur, A., Schaudinn, C., Shuler, C. F., & Costerton, J. W. (2008) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2007.11.035 · Cited by 235
Bisphosphonate-associated osteonecrosis of the jaw: A key role of inflammation?
Lesclous, P., Abi Najm, S., Carrel, J.-P., Baroukh, B., Lombardi, T., Willi, J.-P., Rizzoli, R., Saffar, J.-L., & Samson, J. (2009) · Bone · doi:10.1016/j.bone.2009.07.011 · Cited by 211
Bisphosphonate-Related Osteonecrosis of the Jaw: Is pH the Missing Part in the Pathogenesis Puzzle?
Otto, S., Hafner, S., Mast, G., Tischer, T., Volkmer, E., Schieker, M., Stürzenbaum, S. R., von Tresckow, E., Kolk, A., Ehrenfeld, M., et al. (2010) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2009.07.079 · Cited by 168
Self-citationOtto, S., Abu-Id, M. H., Fedele, S., Warnke, P. H., Becker, S. T., Kolk, A., Mücke, T., Mast, G., Köhnke, R. H., Volkmer, E., et al. (2010) · Journal of Cranio-Maxillofacial Surgery · doi:10.1016/j.jcms.2010.05.009 · Cited by 147
Self-citationOtto, S., Pautke, C., Opelz, C., Westphal, I., Drosse, I., Schwager, J., Bauss, F., Ehrenfeld, M., & Schieker, M. (2010) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2010.07.017 · Cited by 146
Self-citationInhibition of osteoblast function in vitro by aminobisphosphonates
Orriss, I. R., Key, M. L., Colston, K. W., & Arnett, T. R. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21983 · Cited by 134
Sinus Tracts—An Early Sign of Bisphosphonate-Associated Osteonecrosis of the Jaws?
Mawardi, H. H., Treister, N. S., Richardson, P. G. G., Anderson, K. C., Munshi, N. C., Faiella, R. A., & Woo, S. (2009) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2008.09.031 · Cited by 116
Incidence of bisphosphonate‐associated osteonecrosis of the jaws in breast cancer patients
Walter, C., Al‐Nawas, B., du Bois, A., Buch, L., Harter, P., & Grötz, K. A. (2009) · Cancer · doi:10.1002/cncr.24119 · Cited by 82
The Role of Inferior Alveolar Nerve Involvement in Bisphosphonate-Related Osteonecrosis of the Jaw
Otto, S., Hafner, S., & Grötz, K. A. (2009) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2008.09.028 · Cited by 78
Self-citationScavelli, C., Pietro, G. D., Cirulli, T., Coluccia, M., Boccarelli, A., Giannini, T., Mangialardi, G., Bertieri, R., Coluccia, A. M. L., Ribatti, D., et al. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0311 · Cited by 73
Is Zoledronate Toxic to Human Periodontal Fibroblasts?
Agis, H., Blei, J., Watzek, G., & Gruber, R. (2009) · Journal of Dental Research · doi:10.1177/0022034509354298 · Cited by 70
Oizumi, T., Funayama, H., Yamaguchi, K., Yokoyama, M., Takahashi, H., Yamamoto, M., Kuroishi, T., Kumamoto, H., Sasaki, K., Kawamura, H., et al. (2010) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2009.08.027 · Cited by 43
Cited by
Qaseem, A., Forciea, M. A., McLean, R. M., Denberg, T. D., & for the Clinical Guidelines Committee of the American College of Physicians* (2017) · Annals of Internal Medicine · doi:10.7326/m15-1361 · Cited by 676
Crandall, C. J., Newberry, S. J., Diamant, A., Lim, Y.-W., Gellad, W. F., Booth, M. J., Motala, A., & Shekelle, P. G. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0317 · Cited by 254
Metadata
- Authors
- Otto, S., Schreyer, C., Hafner, S., Mast, G., Ehrenfeld, M., Stürzenbaum, S., & Pautke, C.
- Venue
- Journal of Cranio-Maxillofacial Surgery
- Publisher
- Elsevier BV
- Published
- 2012-06
- Volume
- 40
- Issue
- 4
- Pages
- 303-309
- ISSN
- 1010-5182 (ISSN-L)
- OpenAlex
- W1999024824
- Cited by
- 252
- References
- 36
- FWCI
- 8.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.